Clinical Trial

Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project

Study acronym: PEDIACAM
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 29, 2025 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to assess the long-term outcomes of children infected with HIV, having participated in the ANRS 12140 PediacamI study, in terms of: clinical and immunovirological response to ARV therapy, long-term ARV tolerance, and the impact of family environment and lifestyle on adherence to ARV treatment.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2014-01-21; most recent amendment 2025-01-28.
Trial Details
NCT Number NCT02043418
Lead Sponsor ANRS, Emerging Infectious Diseases
Collaborators: Centre Pasteur du Cameroun, Centre Mère et Enfant de la Fondation Chantal Biya, Centre Hospitalier D'essos, Hospital General De Douala, Institut Pasteur, Institut National de la Santé Et de la Recherche Médicale, France, Assistance Publique - Hôpitaux de Paris
Conditions HIV
Enrollment 460 participants
Start Date 2007-11
Primary Completion 2025-07 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2025-01-29